A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved.

The most recent studies about mild cognitive impairment (MCI) are focused on the search for factors that make patients more vulnerable to conversion to dementia, mainly Alzheimer’s disease (AD). The aim of this study was to determine which neuropsychological test performances, including episodic memory profiles, and genetic risk factors (APOE ε4) better predict early conversion to dementia among the four MCI subtypes. Data from 550 MCI patients were analyzed for the purpose of this study and were classified according to Petersen’s criteria (2004), and also taking into account the absence (probable MCI) or presence (possible MCI) of comorbidities that could explain cognitive deficits. MCI cases were divided into Probable amnestic (Pr-aMCI) (n = 115), probable non-amnestic (Pr-naMCI) (n = 37), possible amnestic (Pss-aMCI) (n = 234), and possible non-amnestic (Pss-naMCI) (n = 164), single or multiple domain. In the whole MCI sample, regression analysis showed that low performances on Orientation, Verbal Delayed Recall of the Word List Learning test from WMS-III, and Luria’s Clock test were associated with conversion to dementia, independently of APOE ε4 allele. Cox proportional-hazards showed that the Probable MCI subtype, presence of storage memory impairment, multiple domain condition, and presence of at least one ε4 allele increased the risk of conversion to dementia. Multivariate survival and Kapplan-Meier analyses showed that the Pr-aMCI with storage memory impairment had the most and closest risk of conversion to dementia. In conclusion, the Pr-aMCI subset of patients had 8.5 times more risk of converting to dementia than the Pss-naMCI group, who displayed the slowest conversion rate to dementia.

[1]  M. Trabucchi,et al.  Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration , 2007, International journal of geriatric psychiatry.

[2]  Sara Rosenblum,et al.  Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. , 2006, Archives of general psychiatry.

[3]  J. Becker,et al.  Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. , 2007, Archives of neurology.

[4]  W. Krampla,et al.  Conversion from subtypes of mild cognitive impairment to Alzheimer dementia , 2007, Neurology.

[5]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[6]  G. C. Román,et al.  Vascular dementia , 1993, Neurology.

[7]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[8]  Yaakov Stern,et al.  Frequency and course of mild cognitive impairment in a multiethnic community , 2008, Annals of neurology.

[9]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[10]  M. Freedman,et al.  Frontotemporal lobar degeneration , 1998, Neurology.

[11]  D. Dickson,et al.  Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. , 2004, Archives of neurology.

[12]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[13]  A. Wallin,et al.  The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[15]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[16]  J. Morris,et al.  Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.

[17]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[18]  B. Winblad,et al.  Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  C. Jack,et al.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. , 2004, Archives of neurology.

[20]  R. Corbo,et al.  Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? , 1999, Annals of human genetics.

[21]  A. Wallin,et al.  Cognitive profiles of mild cognitive impairment with and without vascular disease. , 2007, Neuropsychology.

[22]  N. Lassen,et al.  Multi-infarct dementia. A cause of mental deterioration in the elderly. , 1974, Lancet.

[23]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[24]  E G Tangalos,et al.  Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.

[25]  W. Chan,et al.  Importance of Subtle Amnestic and Nonamnestic Deficits in Mild Cognitive Impairment: Prognosis and Conversion to Dementia , 2007, Dementia and Geriatric Cognitive Disorders.

[26]  Bradford C. Dickerson,et al.  Fractionating verbal episodic memory in Alzheimer's disease , 2011, NeuroImage.

[27]  M. Trabucchi,et al.  The Importance of Alzheimer Disease Assessment Scale-cognitive Part in Predicting Progress for Amnestic Mild Cognitive Impairment to Alzheimer Disease , 2008, Journal of Geriatric Psychiatry and Neurology.

[28]  C. Golden,et al.  DIFFERENTIAL PERFORMANCE OF ALZHEIMER'S AND VASCULAR DEMENTIA PATIENTS ON A BRIEF BATTERY OF NEUROPSYCHOLOGICAL TESTS , 2005, The International journal of neuroscience.

[29]  C. Moulin,et al.  Deficient Acquisition and Consolidation: Intertrial Free Recall Performance in Alzheimer’s Disease and Mild Cognitive Impairment , 2004, Journal of clinical and experimental neuropsychology.

[30]  J. Kulisevsky,et al.  Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging , 2003, International journal of geriatric psychiatry.

[31]  N. Herrmann,et al.  Mild Cognitive Impairment: An Operational Definition and Its Conversion Rate to Alzheimer’s Disease , 2005, Dementia and Geriatric Cognitive Disorders.

[32]  S. Riedel-Heller,et al.  Mild cognitive impairment , 2006, Neurology.

[33]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[34]  J. Becker,et al.  A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[35]  Nick C Fox,et al.  Revising the definition of Alzheimer's disease: a new lexicon , 2010, The Lancet Neurology.

[36]  D. Bennett,et al.  The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. , 2005, Neurocase.

[37]  J. Hodges,et al.  Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm , 2009, Journal of Neurology.

[38]  C. Chiandetti,et al.  Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. , 2007, Archives of gerontology and geriatrics.

[39]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[40]  T. Parsons,et al.  NEUROCOGNITIVE DIFFERENTIAL DIAGNOSIS OF DEMENTING DISEASES: ALZHEIMER'S DEMENTIA, VASCULAR DEMENTIA, FRONTOTEMPORAL DEMENTIA, AND MAJOR DEPRESSIVE DISORDER , 2006, The International journal of neuroscience.

[41]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[42]  A. Singleton,et al.  Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[43]  J. Brandt,et al.  The Fate of the 0.5s: Predictors of 2-Year Outcome in Mild Cognitive Impairment , 2010, Journal of the International Neuropsychological Society.

[44]  John Breitner,et al.  Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. , 2003, Archives of neurology.

[45]  A. Kurz,et al.  Progression to Dementia in Clinical Subtypes of Mild Cognitive Impairment , 2006, Dementia and Geriatric Cognitive Disorders.

[46]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[47]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[48]  K. Schmidtke,et al.  High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients , 2008, International Psychogeriatrics.

[49]  J. Becker,et al.  Normative data of a brief neuropsychological battery for Spanish individuals older than 49 , 2012, Journal of clinical and experimental neuropsychology.

[50]  A. Wallin,et al.  Cognitive Profiles of Incipient Dementia in the Goteborg MCI Study , 2010, Dementia and Geriatric Cognitive Disorders.

[51]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .